TTK Healthcare Limited (TTKHLTCARE) AI Stock Analysis

• Market Cap: ₹16.31B
• Dividend Yield: 0.87%
• Average Volume (3M): 217.00
• Price to Earnings (P/E): 25.9
• Beta (1Y): 0.78
• Revenue Growth: 8.10%
• EPS Growth: -19.89%
• Country: IN
• Employees: 1,316
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - General
• EPS (TTM): 9.20
• Shares Outstanding: 14,130,333
• 10 Day Avg. Volume: 88
• 30 Day Avg. Volume: 217
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹1,287.00
• Price Target Upside: 11.47% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 67 Neutral
• Price Target: ₹1,287.00 ▲(11.47% Upside)

TTK Healthcare Limited's overall score is driven by strong financial stability and revenue growth, offset by cash flow challenges and moderate valuation. Technical indicators suggest neutral momentum, with no significant earnings call or corporate events impacting the score.

TTK Healthcare Limited Business Overview & Revenue Model

Company Description

TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally. Its Animal Welfare segment deals in various therapeutic formulations and feed supplements for veterinary use. The company's Consumer Products segment is involved in the marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, Good Home range of scrubbers, air fresheners, etc. its Medical Devices segment manufactures and distributes artificial heart valves; and develops orthopedic implants and instruments. The company's Protective Devices segment manufactures and markets male contraceptives and other allied products. Its Foods segment engages in the manufacturing and marketing of food products, including potato and cereal based pellets. The company's Others segment prints and publishes maps and atlases. Its Human Pharma segment deals in herbal and allopathic formulations for human use. The company was incorporated in 1958 and is headquartered in Chennai, India. TTK Healthcare Limited is a subsidiary of TT Krishnamachari & Co., Ltd.

How the Company Makes Money

TTK Healthcare Limited generates revenue through multiple streams. Its primary source of income is the sale of pharmaceuticals and over-the-counter products, which are distributed through a vast network of pharmacies, hospitals, and healthcare providers. The company also earns revenue from its consumer product line, which includes personal care and hygiene products sold through retail outlets and online platforms. Additionally, TTK Healthcare benefits from partnerships and collaborations with other healthcare entities, enhancing its product offerings and market reach. Research and development initiatives also play a crucial role in introducing innovative products, thereby supporting long-term revenue growth.

TTK Healthcare Limited Financial Statement Overview

Summary

TTK Healthcare Limited shows strong revenue growth and financial stability with a robust balance sheet. However, cash flow management poses challenges, with negative free and operating cash flows despite some improvement.

Income Statement

TTK Healthcare Limited has demonstrated a strong revenue growth trajectory, with a notable increase in total revenue from 2024 to 2025. The gross profit margin is robust, showcasing effective cost management. However, the declining EBITDA margin suggests potential increases in operational costs or inefficiencies.

Balance Sheet

The company maintains a healthy balance sheet with a low debt-to-equity ratio and a strong equity ratio, indicating financial stability and low leverage. The high ROE reflects efficient use of equity to generate profits.

Cash Flow

Cash flow analysis reveals challenges, with negative free cash flow and operating cash flow figures. Although there is an improvement in free cash flow growth year-on-year, the negative operating cash flow to net income ratio highlights ongoing cash management issues.

Breakdown	TTM	Dec 2025	Dec 2023	Dec 2022	Dec 2021	Dec 2021
Income Statement
Total Revenue	8.20B	8.73B	7.48B	7.25B	6.33B	5.96B
Gross Profit	3.71B	5.04B	2.63B	3.77B	3.79B	3.09B
EBITDA	1.26B	1.06B	999.35M	796.81M	373.52M	406.58M
Net Income	816.57M	816.57M	628.42M	6.40B	464.41M	415.88M
Balance Sheet
Total Assets	12.81B	12.81B	12.01B	11.70B	4.94B	5.59B
Cash, Cash Equivalents and Short-Term Investments	7.86B	7.86B	8.45B	8.71B	2.27B	2.73B
Total Debt	242.19M	242.19M	228.11M	273.29M	191.44M	222.13M
Total Liabilities	2.16B	2.16B	2.00B	2.17B	2.00B	2.29B
Stockholders Equity	10.65B	10.65B	10.01B	9.53B	2.95B	3.30B
Cash Flow
Free Cash Flow	0.00	-168.16M	-153.27M	-377.75M	946.88M	385.02M
Operating Cash Flow	0.00	-39.76M	-49.43M	-260.76M	964.21M	449.96M
Investing Cash Flow	0.00	201.03M	284.94M	329.59M	-772.39M	-305.47M
Financing Cash Flow	0.00	-180.81M	-219.11M	-124.26M	-171.56M	-91.40M

TTK Healthcare Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1154.55
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:TTKHLTCARE, the sentiment is Negative. The current price of 1154.55 is below the 20-day moving average (MA) of 1169.41, below the 50-day MA of 1193.26, and below the 200-day MA of 1247.09, indicating a bearish trend. The MACD of -0.72 indicates Negative momentum. The RSI at 44.28 is Neutral, neither overbought nor oversold. The STOCH value of 21.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:TTKHLTCARE.

TTK Healthcare Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AMRUTANJAN	73 Outperform	₹21.06B	38.18	15.56%	0.64%	8.20%	28.19%
WINDLAS	69 Neutral	₹19.52B	29.66	12.06%	0.63%	20.19%	8.71%
VIMTALABS	68 Neutral	₹32.56B	43.89	17.78%	0.14%	15.84%	79.69%
TTKHLTCARE	67 Neutral	₹16.31B	25.86	―	0.87%	8.10%	-19.89%
SMSPHARMA	55 Neutral	₹22.40B	29.99	10.81%	0.16%	10.29%	25.18%
BAJAJHCARE	54 Neutral	₹14.92B	32.90	8.47%	0.21%	17.50%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%